Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...